1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThis Funding Opportunity Announcement invites grant applications for research to examine the impact of Human-Animal Interactions (HAI) on typical and atypical child development and health; the evaluation of animal-assisted intervention for children and adults with disabilities o…
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Non-domestic (non-U. S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U. S.) components of U. S. Organizations are eligible to apply. Confirm the full requirements in the official notice before applying.
The current listing shows up to $50,000 in direct costs per year for a maximum of 2 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Human-Animal Interaction (HAI) Research (R03 Clinical Trial Optional) is funded by National Institutes of Health (NIH) - Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
Small Business Initiatives for Innovative tools and Technologies for Improving Outcomes for Maternal Health, NOT-EB-23-005 is sponsored by National Institutes of Health (NIH) - Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). This Notice of Special Interest (NOSI) seeks to advance maternal health research through small business innovation, focusing on projects for detecting, predicting, and/or monitoring conditions or disorders during pregnancy and/or the post-partum period that contribute to maternal morbidity and mortality. This includes clinical trials. The initiative is part of the 'Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)' initiative. Small businesses are encouraged to develop technologies, remote monitoring systems, clinical analytics platforms, and healthcare delivery solutions. While not explicitly mentioning GIS, the focus on 'clinical analytics platforms' and 'maternal risk prediction' suggests that GIS secondary data analysis could be a relevant tool in developing such innovative solutions.
Explaining State Variability in Pediatric Hospitalizations and Reported Child Maltreatment is sponsored by National Institutes of Health (NIH) - Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). This federal grant supports a collaborative research effort examining state safety net policies to identify whether they improve the health and well-being of children.
Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH) - Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Similar to the R41/R42 mechanism, this R43/R44 SBIR grant supports new entrepreneurs in small businesses focusing on research and development.
NICHD's FY2026 funding strategy applies an automatic 14 percent reduction to every new R01 below the peer-review recommended level, eliminates inflationary increases on future-year commitments, and abandons a fixed payline entirely in favor of priority-driven discretion. The structural implications for child health investigators.
Read articleThe Health and Extreme Weather highlighted topic went live September 1, 2026 with eleven awarding institutes and expires May 1, 2028. There is no set-aside, no separate deadline, and no review criteria — which makes the institute-by-institute language the only real signal, and it is not uniform.
Read articleThe NOURISH Autoimmunity Digital Health Challenge runs three phases to August 2028: 10 winners at $20,000, then 5 at $30,000, then 3 at $100,000. It is a prize competition, not a grant — no indirect costs, no cost reimbursement, and a rule that quietly disqualifies the obvious applicant.
Read article